Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
Ajouter des filtres








Gamme d'année
1.
Article Dans Anglais | IMSEAR | ID: sea-153786

Résumé

Wide spread use of Di-(2-ethylhexyl) phthalate (DEHP) has made it a ubiquitous contaminant in today’s environment, responsible for possible carcinogenic and endocrine disrupting effects. In the present investigation an integrative toxico-proteomic approach was made to study the estrogenic potential of DEHP. In vitro experiments carried out with DEHP (0.1-100 μM) induced proliferations (E-screen assay) in human estrogen receptors-α (ERα) positive MCF-7 and ERα negative MDA-MB-231 breast cancer cells irrespective of their ERα status. Further, DEHP suppressed tamoxifen (a potent anti-breast cancer drug) induced apoptosis in both cell types as shown by flowcytometric cell cycle analysis. Label-free quantitative proteomics analysis of the cell secretome of both the cell lines indicated a wide array of stress related, structural and receptor binding proteins that were affected due to DEHP exposure. The secretome of DEHP treated MCF-7 cells revealed the down regulation of lactotransferrin, an ERα responsive iron transport protein. The results indicated that toxicological effects of DEHP did not follow an ERα signaling pathway. However, the differential effects in MCF-7 and MDA-MB-231 cell lines indicate that ERα might have an indirect modulating effect on DEHP induced toxicity.


Sujets)
Apoptose/effets des médicaments et des substances chimiques , Tumeurs du sein/anatomopathologie , Cycle cellulaire/effets des médicaments et des substances chimiques , Division cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale/métabolisme , Phtalate de bis[2-éthylhexyle]/toxicité , Polluants environnementaux/toxicité , Récepteur alpha des oestrogènes/effets des médicaments et des substances chimiques , Récepteur alpha des oestrogènes/physiologie , Oestrogènes , Femelle , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Humains , Lactoferrine/biosynthèse , Lactoferrine/génétique , Lactoferrine/métabolisme , Cellules MCF-7/effets des médicaments et des substances chimiques , Cellules MCF-7/métabolisme , Spectrométrie de masse/instrumentation , Microchimie/instrumentation , Protéines tumorales/effets des médicaments et des substances chimiques , Protéines tumorales/physiologie , Protéines tumorales/métabolisme , Tumeurs hormonodépendantes/anatomopathologie , Protéomique , Tamoxifène/antagonistes et inhibiteurs , Tamoxifène/pharmacologie
2.
J. appl. oral sci ; 20(2): 180-185, Mar.-Apr. 2012. ilus
Article Dans Anglais | LILACS | ID: lil-626418

Résumé

OBJECTIVES:The aim of this study was to compare the pattern of secretion and the expression of mucin glycoprotein-2 (MG2) and lactoferrin in individuals with or without periodontitis. MATERIAL AND METHODS: Five individuals with aggressive periodontitis (APG), 5 with generalized chronic periodontitis (CPG) and 5 without periodontitis (CG) were enrolled after informed consent. Non-stimulated and stimulated submandibular and sublingual saliva was collected and samples analyzed by Western blot probed with specific antibodies. RESULTS: Stimulated and non-stimulated salivary flow rates did not differ among groups. Western blot analysis revealed that stimulation led to: an increase in MG2 expression in all groups, and to lactoferrin expression in APG and CPG. In non-stimulated saliva, CG exhibited the highest expression of both glycoproteins. In stimulated saliva, CG exhibited the highest expression of MG2, whereas APG the highest of lactoferrin. CONCLUSIONS: The pattern of secretion of MG2 and lactoferrin in health and disease is complex. Although the present study analyzed samples from a limited number of participants, the reduced expression of MG2 and lactoferrin in APG and CPG under non-stimulated condition, the predominant circumstance of salivary secretion during the day, suggests that these salivary constituents may play a role in the etiopathogenesis of these diseases.


Sujets)
Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Parodontite agressive/métabolisme , Parodontite chronique/métabolisme , Lactoferrine/analyse , /analyse , Salive/composition chimique , Glandes salivaires , Technique de Western , Études cas-témoins , Électrophorèse sur gel de polyacrylamide , Lactoferrine/métabolisme , /métabolisme , Débit sécrétoire , Facteurs temps
3.
Braz. j. med. biol. res ; 24(9): 889-93, Sept. 1991. tab
Article Dans Anglais | LILACS | ID: lil-102095

Résumé

The objetive of this study was to compare lactoferrin (LF) levels and unsaturated iron-binding capacity (UIBC) of colostrum from Brazilian women aged 20-38 years of low (N = 28) and high (N = 15) socioeconomic level. Both groups received a similar amount of supplental iron (25-65 mg/day) during pregnancy. We also determined the relationship between LF levels and UIBC, and between these components and maternal iron status. Both groups (low and high socieconomic level) showed adequate and similar mean hematocrit (35.0 ñ 13% and 35.9 ñ 1.3%, respectively) and serum ferritin (64 ñ 12 µg/1 and 57 ñ 12 µg/1, respectively) levels. Furthermore, LF levels (5.7 ñ 0.9 mg/ml and 5.5 ñ 0.6 mg/ml) and UIBC (3.8 ñ 0.3 µg/ml and 3/1 ñ 0.3 µg/ml) were not significantly different in the two groups of women, nor were they related to maternal hematocrit or serum ferritin. UIBC was significantly (P = 0.009), although weakly positively correlated (r= 0.45) with LF levels, suggesting that other colostrum ligands may contribute substantially to the capacity of colostrum to bind exogenous iron


Sujets)
Humains , Femelle , Grossesse , Adulte , Colostrum/métabolisme , Fer/métabolisme , Lactoferrine/métabolisme , Brésil , Ferritines/sang , Hématocrite , Fer/administration et posologie , Dosage radioimmunologique , Facteurs socioéconomiques
SÉLECTION CITATIONS
Détails de la recherche